The things worth building rarely come easy. You are creating solutions that move the needle in the physical world. You turn the difficult into something that works. And once it works, the hard part isn’t over. That’s where we come in. Sandwater is a venture capital firm that turns early proof into lasting success.
Who we back
Who we are
News
News Archive
06/07/2026CurifyLabs raises €12M Series A to power the future of personalized medicine
02/07/2026Alva Industries secures €16 million to scale breakthrough electric motor technology
08/06/2026Gardar launches a new Norwegian defence fund for Ukraine, operated by Sandwater
03/06/2026Why we believe Mantle8 rocks
13/05/2026Mantle8 raises €31M in Series A funding for natural hydrogen
12/05/2026Sandwater expands to Munich, brings in Alexander Domin as partner
07/04/2026XO Life closes 4 million euros in new funding
09/03/2026The Sandbox: How Sandwater turns data into venture insights
28/10/20251X launches NEO, the world's first consumer-ready humanoid robot
16/09/2025Nofence has raised $35 million in Series B funding
01/09/2025Adele Unneberg speaking at the Nordic Climate Finance Summit
05/08/2025Why did we invest in Filics?
07/07/2025New investment in Filics Series A
16/06/2025Katherine Mellis to host a roundtable at the Drop
04/06/2025Jeremy Clarkson adopts Nofence's technology
19/05/2025Sandwater partner Torkel Engeness discusses defense technology in Shifter.no
03/05/2025Largest delivery of Antec’s reactors to Norway
23/04/2025Cytovation raises $6M to advance phase 2 development
03/04/2025Sandwater welcomes Chloe Fu and Didrik Dewan to the team
02/04/2025Partner Tom Even Mortensen guests the Nysnø podcast
23/03/20251X and Nvidia announce research collaboration
23/03/2025Bioenergy innovation award to Antec Biogas
17/03/2025The femtech startups to watch, according to investment director Katherine Mellis
10/03/2025Sandwater welcomes Reetta Heiskanen to the team
03/02/2025New investment in Enduro Genetics’ Series A
28/01/2025XO Life rebrands their ImpactMonitor to brite
23/01/2025Cytovation's latest collaboration to advance treatment for rare cancer
15/10/2024CMR Surgical receives U.S. FDA marketing authorization
03/09/2024New investment in Soil Capital's series B
21/08/2024New investment in XO Life’s €7m seed round
24/05/2024Farminsect announces strategic partnership with AGRAVIS
08/04/2024CardioSignal presents heart failure study results
27/03/2024Ranchers embrace virtual fencing for greener pastures
14/03/2024CardioSignal publishes a population health study
23/01/2024New investment in CardioSignal's Series A
11/01/20241X announces $100M Series B
10/01/2024Sandwater announces successful final close of venture fund at €125M
23/10/2023New investment announced into Farminsect
11/10/2023Cytovation reports promising result from Phase 1/2a Cicilia Study
05/06/2023Cytovation raises $8 million in Series A extension
23/03/20231X raises $23.5M in Series A2 funding led by OpenAI
03/02/2023Adele Unneberg joins the Sandwater investment team
28/10/2022Cytovation presents Phase I dose escalation at ESMO
26/01/2022Cytovation raises $20 million in Series A financing